Pfizer, BioNTech face continued UPC infringement suit over Covid vaccine patent
MLex Summary: The Unified Patent Court has ruled that the patent infringement case brought by Promosome against Pfizer and BioNTech — over its EP 2,401,365 used in Comirnaty Covid-19 vaccine variants...To view the full article, register now.
Already a subscriber? Click here to view full article